BOMSS Bariatric Fellowships 2014

The British Obesity and Metabolic Surgical Society (BOMSS) with the generous financial support of Ethicon Endo Surgery are pleased to be able to offer four Bariatric fellowships of 12 months duration commencing October 2014. The national fellowship programme has been in place for 6 years and has the educational approval of the Royal College of Surgeons of England.

Fellowships are hosted in Musgrove Park Hospital Taunton, University College Hospital London, Sunderland Royal Hospital and North Tyneside Hospital Tyne and Wear.Please see the full job descriptions below:

Please apply by submitting a curriculum vitae, a letter of support from your current consultant and your reasons for applying for the fellowship, along with the completed Fellowship Preference Form to:

Miss Sarvjit Madhar,
The Royal College of Surgeons of England
35/43 Lincoln’s Inn Fields,
London, WC2A 3PE

T:  020 7304 4773      F: 020 7430 9235
E: sarvjit@augis.orgDates to note:
Friday 14th March 2014     Closing date for Applications
Friday 21st March 2014     Successful candidates will be informed.
Friday 4th April 2014          Interviews held at the Royal College of Surgeons of England

BOMSS gathers in Glasgow

World-class surgeons and allied health professionals will gather in Glasgow next week for the 4th Annual Meeting of BOMSS (January 24-25).

National and international speakers will address the conference on a range of key topics around obesity and bariatric surgery. Subjects covered will include metabolic surgery for diabetes, weight-loss surgery training in the UK, multi-disciplinary working and the European experience.

Professor Duff Bruce, BOMSS Council member, consultant surgeon at Aberdeen Royal Infirmary and lead organiser for the Scientific Meeting, said: “I’m delighted to welcome so many experts to Scotland. Weight-loss surgery is the most clinically effective, safe and cost-effective treatment available for many patients with severe obesity-related diseases.

“BOMSS’ UK-wide National Registry (NBSR) outcomes have been congruent with international data, suggesting that 85% of surgically-treated type 2 diabetics had benefitted and had stopped medications by two years after their procedure.”

Click here to register for the conference: